Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 39/100

Termination Rate

12.5%

3 terminated out of 24 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

54%

13 trials in Phase 3/4

Results Transparency

58%

7 of 12 completed with results

Key Signals

7 with results80% success

Data Visualizations

Phase Distribution

19Total
Not Applicable (1)
P 1 (2)
P 2 (3)
P 3 (7)
P 4 (6)

Trial Status

Completed12
Terminated3
Unknown2
Not Yet Recruiting2
Active Not Recruiting2
Withdrawn2

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (24)

Showing 20 of 20 trials
NCT07423442Not Yet Recruiting

Frequency and Intensity of Inflammatory Relapses in Patients With Non-infectious Posterior Uveitis Treated With a Fluocinolone Acetonide Implant

NCT06431373Phase 3Active Not RecruitingPrimary

A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis

NCT05486468Phase 3Recruiting

The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment

NCT06743906Not Yet RecruitingPrimary

Role of OCT & OCT Angiography in Patients With Posterior at the Uveitis Clinic of Assiut University Hospital.

NCT05101928Phase 4WithdrawnPrimary

Ozurdex Monotherapy Trial

NCT05070728Phase 3Terminated

Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal (FAI) Insert

NCT05322070Phase 4Active Not RecruitingPrimary

Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis

NCT06085079Phase 4UnknownPrimary

Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study

NCT03656692Phase 4TerminatedPrimary

Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)

NCT03097315Phase 3Completed

Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis

NCT02952001Completed

MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301

NCT02595398Phase 3Completed

Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis

NCT02255032Phase 2Completed

Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis

NCT03066869Phase 4UnknownPrimary

Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis

NCT02049476Phase 4Completed

Study of the Effectiveness of Ozurdex for the Control of Uveitis

NCT03145025CompletedPrimary

Corneal Endothelial Cell Density in Eyes Treated With a Fluocinolone Acetonide Intravitreal Implant

NCT03598452Not ApplicableCompleted

High-dose Intravitreal Injection of Ganciclovir for the Treatment of CMVR in HIV-negative Patients

NCT01905124Phase 2WithdrawnPrimary

Safety &Efficacy of CF101 to Subjects With Uveitis

NCT02125266Phase 1TerminatedPrimary

Safety and Preliminary Efficacy Study of V404 PDS in Uveitis

NCT01539577Completed

A Long-Term Safety Study of OZURDEX® in Clinical Practice

Scroll to load more

Research Network

Activity Timeline